A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy

Allison J. Greaney(University of Washington), Jesse D. Bloom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Tyler N. Starr(University of Utah), Rachel Eguia(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sandile Cele(Africa Health Research Institute), John E. Bowen(University of Washington), Jennifer K. Logue(University of Washington), Davide Corti(Vir Biotechnology (Switzerland)), Khadija Khan(Africa Health Research Institute), Alex Sigal(Hebrew University of Jerusalem), Andrea N. Loes(Howard Hughes Medical Institute), David Veesler(Howard Hughes Medical Institute), Farina Karim(Africa Health Research Institute), Helen Y. Chu(Seattle Pacific University)
bioRxiv (Cold Spring Harbor Laboratory)
October 13, 2021
10.1101/2021.10.12.464114
Cited by 15

Related Papers

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
|Nature|2021|1.2k
Dynamics of the p53-Mdm2 feedback loop in individual cells
|Nature Genetics|2004|1k
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021
|JAMA|2022|909
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
|bioRxiv (Cold Spring Harbor Laboratory)|2020|764
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
|Nature|2021|713